Radical cystectomy with pelvic lymph node dissection is the standard treatment for muscle-invasive bladder cancer and high-risk non-muscle-invasive disease, but its safety in elderly patients remains debated. Bladder cancer incidence increases with age, and approximately 46 percent of patients diagnosed in the United States between 2013 and 2017 were 80 years or older. With global population aging accelerating, the number of octogenarians needing radical cystectomy will continue to grow.
Older patients face greater anesthesia risks, more comorbid conditions, and shorter life expectancy that often deter physicians and patients from pursuing cystectomy. Current guidelines do not exclude elderly patients from radical cystectomy but recommend that life expectancy be considered in treatment decisions. Historically, concerns about perioperative morbidity have led to undertreatment of elderly bladder cancer patients despite evidence that cystectomy provides survival benefit even in older age groups.
Robot-assisted radical cystectomy reduces blood loss, transfusion rates, and hospital stay compared to open surgery. Prior meta-analyses of laparoscopic and robotic approaches demonstrated that minimally invasive techniques offer advantages in intraoperative damage control and postoperative recovery without compromising oncologic outcomes. These benefits may be especially important for elderly patients who have less physiological reserve to tolerate the morbidity of open radical cystectomy.
Limited data existed on the outcomes of robot-assisted radical cystectomy specifically in octogenarians. Prior studies comparing elderly and younger patients undergoing cystectomy had included open and laparoscopic approaches together or examined smaller robotic cohorts. This study was designed to provide comparative perioperative and oncologic data from a single-surgeon robotic cystectomy series to clarify whether RARC is safe and feasible for patients aged 80 and older.
190 consecutive patients with urothelial carcinoma of the bladder who underwent robot-assisted radical cystectomy between May 2015 and December 2018 were included. All operations were performed by a single experienced surgeon at Nanjing Drum Tower Hospital. Patients were divided into two groups by age: 44 octogenarians aged 80 or older and 146 younger patients under 80. The main indications were primary muscle-invasive transitional cell carcinoma in 38 percent and high-risk non-muscle-invasive disease including CIS, refractory pTa-T1, or BCG-unresponsive tumors in 62 percent.
All patients underwent robot-assisted radical cystectomy using the da Vinci Si platform with three urinary diversion options. Urinary diversion included ileal conduit, orthotopic neobladder, or ureterostomy, with the choice made based on patient physical condition and preference. Pelvic lymph node dissection was performed at the surgeon's discretion and was less commonly performed in the elderly group (75 percent versus 89 percent, p equals 0.019).
Postoperative complications were graded using the standardized Clavien-Dindo system up to 90 days after surgery. Minor complications were classified as grades 1 and 2, while major complications were grades 3, 4, and 5. All pathological specimens were graded according to 2016 WHO classification standards and staged by 8th edition AJCC TNM staging. The Charlson comorbidity index and ASA score were used as preoperative functional assessments.
Cox regression and logistic regression analyses identified independent predictors of complications and survival outcomes. Univariable and multivariable logistic regression analyzed factors predicting high-grade and any-grade complications. Cox multivariable regression evaluated predictors of 3-year overall survival, recurrence-free survival, and cancer-specific survival. Kaplan-Meier curves with log-rank testing compared survival distributions between age groups.
Octogenarians and younger patients did not differ significantly in most perioperative and pathological characteristics. Groups were similar in BMI, ASA score distribution, CCI class, estimated blood loss, postoperative hospital stay, pathological T stage, lymph node status, lymphovascular invasion, and surgical margin positivity. The median operating time was significantly shorter in the elderly group at 308 minutes versus 399 minutes for younger patients, likely because surgeons chose simpler urinary diversion and operated more efficiently to minimize anesthesia duration.
Transfusion rates were higher in elderly patients (47.7 percent versus 28.1 percent, p equals 0.015), reflecting lower preoperative hemoglobin and more conservative transfusion thresholds. Median preoperative hemoglobin was lower in the elderly group at 119 g/L versus 126 g/L. Surgeons and anesthesiologists may relax transfusion thresholds in elderly patients given concerns about frailty and limited compensatory reserve after blood loss, though perioperative transfusion is itself associated with increased cancer recurrence and mortality risk after radical cystectomy.
Complication rates were similar between groups, with any-grade complications in 50 percent of octogenarians and 54.8 percent of younger patients. High-grade complications occurred in 9.1 percent of elderly and 6.2 percent of younger patients. The most common complications in both groups were postoperative ileus and urinary tract infection. Re-operation was required in 4.5 percent of elderly and 4.1 percent of younger patients. No statistically significant difference was found between groups in complication grade distribution or 90-day mortality.
ASA score predicted high-grade complications while Charlson comorbidity index predicted any-grade complications, but age did not independently predict either complication category. On multivariable logistic regression, ASA score greater than 2 carried an odds ratio of 4.662 for high-grade complications (p equals 0.045), and each unit increase in CCI carried an odds ratio of 1.608 for any-grade complications (p equals 0.035). After adjustment for all covariates, octogenarian age was not associated with increased risk of blood loss, transfusion, prolonged hospitalization, or major complications.
Three-year recurrence-free survival was similar between age groups at 72.3 percent for younger patients and 54.4 percent for octogenarians, without reaching statistical significance. The log-rank p value for recurrence-free survival comparison was 0.147, indicating that elderly patients do not face meaningfully higher cancer recurrence risk after successful robotic radical cystectomy compared to younger patients. On multivariable Cox regression, octogenarian age was not an independent predictor of recurrence-free survival (hazard ratio 1.096, p equals 0.806).
Overall survival and cancer-specific survival were significantly worse in octogenarians compared to younger patients. Three-year overall survival and cancer-specific survival differed significantly between groups on Kaplan-Meier analysis (p equals 0.007 and p equals 0.027 respectively). However, after multivariable adjustment, age was not an independent predictor of cancer-specific survival (hazard ratio 1.455, p equals 0.337), suggesting that worse overall and cancer-specific survival in elderly patients is partly attributable to competing comorbidities and treatment-related decisions rather than age itself.
Pathological T stage and lymph node positivity were the dominant independent predictors of all three survival outcomes. pT stage 3 or higher predicted recurrence-free survival (hazard ratio 3.206, p less than 0.001), cancer-specific survival (hazard ratio 5.369, p less than 0.001), and overall survival (hazard ratio 4.553, p less than 0.001). Positive lymph node status similarly predicted all three outcomes with hazard ratios of 3.6 to 4.4. These tumor-related factors outweighed age as determinants of oncologic outcome after robotic cystectomy.
ASA score independently predicted overall survival and CCI independently predicted recurrence-free survival, confirming the importance of functional status assessment. ASA score greater than 2 carried a hazard ratio of 2.076 for overall survival (p equals 0.048), while each unit increase in CCI carried a hazard ratio of 1.812 for recurrence-free survival (p equals 0.003). These findings support using validated functional assessment tools rather than age alone to guide candidate selection for radical cystectomy in elderly patients.
The incidence of postoperative complications in elderly patients undergoing robotic cystectomy was lower than reported in prior open cystectomy series, suggesting RARC offers meaningful morbidity advantages for older patients. In historical open radical cystectomy cohorts of elderly patients, complication rates were substantially higher. The minimally invasive platform's reduced blood loss and faster recovery may specifically benefit elderly patients with limited physiological reserve who are less able to tolerate major open surgery and its associated morbidity.
Pelvic lymph node dissection was performed less frequently in elderly patients, which may have contributed to their worse overall survival. Prior studies have demonstrated that extended lymphadenectomy improves recurrence-free and disease-specific survival after radical cystectomy. The lower lymph node dissection rate in octogenarians (75 percent) compared to younger patients (89 percent) reflects multidisciplinary decisions balancing anesthetic risk against oncologic benefit, but may have contributed to the observed overall survival difference between groups.
Ureterostomy was chosen more frequently for elderly patients as a simpler urinary diversion with lower operative complexity. The elderly group underwent ureterostomy in 43 percent of cases compared to 28 percent of younger patients, while ileal neobladder was not used in any elderly patient. Simpler urinary diversion reduces operative time and bowel involvement, both important considerations for minimizing anesthetic exposure and postoperative ileus risk in elderly patients. Prior studies have confirmed that cutaneous ureterostomy does not negatively impact quality of life compared to ileal conduit for elderly patients with relevant comorbidities.
Age alone should not determine candidacy for radical cystectomy in elderly bladder cancer patients. The absence of age as an independent predictor of complications or oncologic recurrence suggests that comprehensive preoperative assessment using ASA score, Charlson comorbidity index, and geriatric evaluation tools provides more clinically relevant risk stratification than chronological age. Elderly patients with good functional status who can tolerate surgery may achieve equivalent cancer control to younger patients and deserve consideration for curative robotic radical cystectomy.
Robot-assisted radical cystectomy can be safely performed in selected octogenarians with perioperative outcomes comparable to younger patients. The study demonstrates that elderly age itself does not increase the risk of surgical complications, major morbidity, or oncologic recurrence after robotic radical cystectomy. When octogenarians are carefully selected based on functional status and comorbidity burden, RARC provides a feasible curative treatment option for bladder cancer.
Preoperative comprehensive assessment using validated tools including ASA score and Charlson comorbidity index is essential for elderly patient selection. These functional measures predicted complications and survival independently of age, providing actionable criteria for multidisciplinary decision making. Geriatric assessment tools should be incorporated into routine preoperative evaluation to identify elderly patients who will benefit from curative surgical intent versus those better served by bladder-sparing or palliative approaches.
The study has limitations including its retrospective design, single-center single-surgeon series, and modest elderly patient cohort size. Follow-up data on exact recurrence timing and cause of death may be incomplete in retrospective records. Quality of life and functional outcomes after cystectomy were not measured in this cohort and represent an important gap for future comparative studies between age groups. Selection bias inherent to the RARC cohort means that only relatively healthy elderly patients were included, potentially underrepresenting frailer octogenarians who were triaged to non-surgical management.
Future studies should expand elderly patient cohorts, prolong follow-up, and incorporate quality of life measurement to provide more complete evidence for guideline-level recommendations. Multi-institutional prospective registries of robotic radical cystectomy in octogenarians would provide the sample sizes needed to identify subgroups of elderly patients most likely to benefit from surgery. Integrating geriatric frailty assessment, quality of life endpoints, and functional recovery trajectories alongside perioperative and oncologic outcomes would enable more individualized and evidence-based decision making for elderly bladder cancer patients.